Full Text View
Tabular View
No Study Results Posted
Related Studies
New Approaches to Cocaine Abuse Medications (B) - 7
This study has been completed.
Study NCT00000272   Information provided by National Institute on Drug Abuse (NIDA)
First Received: September 20, 1999   Last Updated: June 23, 2005   History of Changes

September 20, 1999
June 23, 2005
March 1995
 
  • Side effects
  • Craving
  • Drug use
  • Retention
  • Depression
Same as current
Complete list of historical versions of study NCT00000272 on ClinicalTrials.gov Archive Site
 
 
 
New Approaches to Cocaine Abuse Medications (B) - 7
New Approaches to Cocaine Abuse Medications (B)

The purpose of this study is to measure the effect of risperidone in cocaine abusers.

 
Phase II
Interventional
Treatment
  • Cocaine-Related Disorders
  • Substance-Related Disorders
Drug: Risperidone
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
0
 
 

Please contact site for information.

Both
18 Years to 60 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00000272
 
NIDA-09236-7, P50-09236-7
National Institute on Drug Abuse (NIDA)
New York State Psychiatric Institute
Principal Investigator: Herbert Kleber, M.D. New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)
March 1995

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP